comparemela.com

Chengdu Hi Tech Zone News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Chipscreen NewWay: First Patient Dosed in Phase 1 Trial of the Bispecific Antibody NWY001, a Next-generation Tumor Immunotherapy in Patients with Advanced Solid Tumors

/PRNewswire/ Chengdu Chipscreen NewWay Biosciences Co., Ltd. (NewWay) announced that on January 5, 2024, the dosing of the first patient for a phase I.

Hong kongUnited statesSan franciscoChipscreen newway biosciencesChipscreen newwayHaimen jiangsuChipscreen biosciencesChipscreen biosciences united statesShenzhen chipscreen pharmaceuticals co ltdShanghai business centerBiocytogen pharmaceuticals beijing co ltdPrnewswire chengdu chipscreen newway biosciences co ltdShenzhen chipscreen biosciences co ltdSun yat sen university cancer centerChengdu chipscreen pharmaceuticals co ltdEucure beijing biopharma co ltd

Chengdu Hi-tech Zone Jiaozi Avenue Metaverse District Opens on the 1st Day of the New Year

On the evening of January 1st, amid the footfalls of the New Year, a dream-like welcoming performance was showcased on Jiaozi Avenue in Chengdu Hi-tech Zone, signifying the official opening of the Metaverse District on Jiaozi Avenue with the full integration of digital technology and consumption scenarios.

Chengdu cultural equity exchangeTianfu twin towersJiaozi ringJiaozi avenueTwin towersChengdu hi tech zoneMetaverse districtAttachments linksChengdu hi techDigital technologyChengdu cultural equity exchange

Newly Opened Metro Line in Chengdu, China Connects Two International Airports

/PRNewswire/ On November 28, Chengdu, China opened a new metro line, Line 19 Phase II, which, unlike previous ones, not only marks the city s rail transit.

United statesDong weiUnited kingdomScience city campus of chengdu branchTianfu international airportShuangliu international airportChinese academy of sciencesChengdu branchChengdu metroChengdu hi tech zoneDisplay industryScience city campusChinese academyVice presidentScience cityQinghai tibet plateau

Biocytogen s Subsidiary Eucure Biopharma and Chipscreen Biosciences Holding Subsidiary Chipscreen NewWay Biosciences Enter into Greater China License Agreement for Bispecific Antibody YH008

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ( Biocytogen , HKEX: 02315) today announced that its wholly owned subsidiary, Eucure (Beijing) Biopharma Co., Ltd. (“Eucure Biopharma”), has reached an exclusive licensing agreement with Chipscreen NewWay Biosciences (“Chipscreen NewWay”), a holding subsidiary of Shenzhen Chipscreen Biosciences Co., Ltd.

United statesHong kongBaden wübergHaimen jiangsuChipscreen newway biosciencesChipscreen biosciencesYuelei shenEucure biopharmaChipscreen newwayXianping luEucure beijing biopharma co ltdDrug administrationBiocytogen pharmaceuticals beijing co ltdHead of the centerShenzhen chipscreen biosciences co ltdGreater china

AstraZeneca launches TCM innovation center in SW China

AstraZeneca launches TCM innovation center in SW China
macaubusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from macaubusiness.com Daily Mail and Mail on Sunday newspapers.

City ofUnited kingdomTech industrial development zoneSichuan provinceChengdu hi tech industrial development zoneChengdu hi tech zone

vimarsana © 2020. All Rights Reserved.